N-terminal pro-B-type natriuretic peptide as an indicator of disease severity in a heterogeneous group of patients with chronic precapillary pulmonary hypertension.

作者: Arne K. Andreassen , Ragnhild Wergeland , Svein Simonsen , Odd Geiran , Cecilia Guevara

DOI: 10.1016/J.AMJCARD.2006.02.061

关键词: MedicineSeverity of illnessSurvival rateInternal medicineHemodynamicsBrain natriuretic peptideRespiratory diseaseCardiologyNatriuretic peptidePulmonary hypertensionCardiac catheterization

摘要: N-terminal-pro-B-type natriuretic peptide (NT-pro-BNP) is well established as a predictor of prognosis in patients with left ventricular dysfunction. Although similar prognostic significance has been suggested 1 study right failure and idiopathic pulmonary arterial hypertension, NT-pro-BNP not assessed marker disease severity more heterogenous group chronic precapillary hypertension (PH). Hence, this plasma other clinical variables 61 consecutively recruited various forms PH. Right-sided cardiac catheterization cardiopulmonary exercise testing were performed at baseline, the was investigated mean follow-up 25 months. Compared age-matched controls (n = 10), significantly greater those 16), PH associated diseases 26), thromboembolic 19) correlated hemodynamic functional capacity. In 17 medically treated patients, significant decrease levels improved hemodynamics. During follow-up, 15 died from causes. Baseline an independent mortality. Kaplan-Meier survival analysis according to median value (168 pmol/L) demonstrated higher mortality rate supramedian values than low (p 0.010). conclusion, these findings suggest that PH, can be used determine independently long-term

参考文章(14)
Tetsuji Sudoh, Kenji Kangawa, Naoto Minamino, Hisayuki Matsuo, A new natriuretic peptide in porcine brain Nature. ,vol. 332, pp. 78- 81 ,(1988) , 10.1038/332078A0
Horst Olschewski, Dieter Walmrath, Ralph Schermuly, H Ardeshir Ghofrani, Friedrich Grimminger, Werner Seeger, Aerosolized Prostacyclin and Iloprost in Severe Pulmonary Hypertension Annals of Internal Medicine. ,vol. 124, pp. 820- 824 ,(1996) , 10.7326/0003-4819-124-9-199605010-00006
Michael McGoon, David Gutterman, Virginia Steen, Robin Barst, Douglas C. McCrory, Terry A. Fortin, James E. Loyd, Screening, Early Detection, and Diagnosis of Pulmonary Arterial Hypertension: ACCP Evidence-Based Clinical Practice Guidelines Chest. ,vol. 126, pp. 14- ,(2004) , 10.1378/CHEST.126.1_SUPPL.14S
Vallerie V. McLaughlin, Kenneth W. Presberg, Ramona L. Doyle, Steven H. Abman, Douglas C. McCrory, Terry Fortin, Gregory Ahearn, Prognosis of pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines. Chest. ,vol. 126, ,(2004) , 10.1378/CHEST.126.1_SUPPL.78S
Noritoshi Nagaya, Toshio Nishikimi, Masaaki Uematsu, Toru Satoh, Shingo Kyotani, Fumio Sakamaki, Mikio Kakishita, Kengo Fukushima, Yoshiaki Okano, Norifumi Nakanishi, Kunio Miyatake, Kenji Kangawa, Plasma Brain Natriuretic Peptide as a Prognostic Indicator in Patients With Primary Pulmonary Hypertension Circulation. ,vol. 102, pp. 865- 870 ,(2000) , 10.1161/01.CIR.102.8.865
Hanno H. Leuchte, Claus Neurohr, Rainer Baumgartner, Michael Holzapfel, Wolfgang Giehrl, Michael Vogeser, Jürgen Behr, Brain natriuretic peptide and exercise capacity in lung fibrosis and pulmonary hypertension. American Journal of Respiratory and Critical Care Medicine. ,vol. 170, pp. 360- 365 ,(2004) , 10.1164/RCCM.200308-1142OC
Noritoshi Nagaya, Motomi Ando, Hideo Oya, Yutaka Ohkita, Shingo Kyotani, Fumio Sakamaki, Norifumi Nakanishi, Plasma brain natriuretic peptide as a noninvasive marker for efficacy of pulmonary thromboendarterectomy The Annals of Thoracic Surgery. ,vol. 74, pp. 180- 184 ,(2002) , 10.1016/S0003-4975(02)03654-8
STUART RICH, Primary Pulmonary Hypertension Annals of Internal Medicine. ,vol. 107, pp. 216- 223 ,(1987) , 10.7326/0003-4819-107-2-216
D Mukerjee, L.B Yap, A.M Holmes, D Nair, P Ayrton, C.M Black, J.G Coghlan, Significance of plasma N-terminal pro-brain natriuretic peptide in patients with systemic sclerosis-related pulmonary arterial hypertension Respiratory Medicine. ,vol. 97, pp. 1230- 1236 ,(2003) , 10.1016/S0954-6111(03)00254-3
James A de Lemos, Darren K McGuire, Mark H Drazner, B-type natriuretic peptide in cardiovascular disease The Lancet. ,vol. 362, pp. 316- 322 ,(2003) , 10.1016/S0140-6736(03)13976-1